These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6427996

  • 1. T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation.
    Ueda M, Harada M, Shiobara S, Nakao S, Kondo K, Odaka K, Matsue K, Mori T, Hattori K.
    Transplantation; 1984 Jun; 37(6):552-6. PubMed ID: 6427996
    [Abstract] [Full Text] [Related]

  • 2. Immunological reconstitution after allogeneic and autologous bone marrow transplantation.
    Harada M, Ueda M, Nakao S, Kondo K, Odaka K, Shiobara S, Matsue K, Mori T, Hattori K.
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):245-52. PubMed ID: 2939601
    [Abstract] [Full Text] [Related]

  • 3. Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity.
    Chudwin DS, Cowan MJ, Wara DW, Ammann AJ.
    Clin Immunol Immunopathol; 1983 Jan; 26(1):126-36. PubMed ID: 6223739
    [Abstract] [Full Text] [Related]

  • 4. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
    Haas GS, Halperin E, Doseretz D, Linggood R, Russell PS, Colvin R, Barrett L, Cosimi AB.
    J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
    [Abstract] [Full Text] [Related]

  • 5. T lymphocyte reconstitution following autologous bone marrow transplantation.
    Singer CR, Tansey PJ, Burnett AK.
    Clin Exp Immunol; 1983 Mar; 51(3):455-60. PubMed ID: 6303653
    [Abstract] [Full Text] [Related]

  • 6. Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, interleukin 2, and a prostaglandin inhibitor, WY-18251.
    Antonacci AC, Calvano SE, Reaves LE, Prajapati A, Bockman R, Welte K, Mertelsmann R, Gupta S, Good RA, Shires GT.
    Clin Immunol Immunopathol; 1984 Feb; 30(2):304-20. PubMed ID: 6229378
    [Abstract] [Full Text] [Related]

  • 7. Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlations.
    Schandené L, Vanden Steen F, Romasco F, Wybran J.
    Clin Immunol Immunopathol; 1983 Aug; 28(2):147-54. PubMed ID: 6223764
    [Abstract] [Full Text] [Related]

  • 8. Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy.
    Van Es A, Tanke HJ, Baldwin WM, Oljans PJ, Ploem JS, Vanes LA.
    Clin Exp Immunol; 1983 Apr; 52(1):13-20. PubMed ID: 6345032
    [Abstract] [Full Text] [Related]

  • 9. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
    Lum LG, Joshi ID, Galoforo SC, Abella E, Karanes C, Ratanatharathorn V, Schultz KR, Uberti JP, Sensenbrenner LL, Ledbetter JA.
    Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
    [Abstract] [Full Text] [Related]

  • 10. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C, Roldán E, Rodríguez C, Pérez de Oteyza J, Oteho E, López J, Maldonado MS, García Laraña J, Muñoz A, Odriozola J, Brieva JA.
    Med Clin (Barc); 1999 Jun 12; 113(1):1-5. PubMed ID: 10422068
    [Abstract] [Full Text] [Related]

  • 11. Immunological monitoring of diabetic and nondiabetic recipients of renal allografts.
    Delmonico FL, Cosimi AB, Jaffers GJ, Schooley RT, Rubin RH, Tolkoff-Rubin N, Fang LT, Russell PS.
    J Surg Res; 1983 Oct 12; 35(4):271-6. PubMed ID: 6225908
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. T-cell phenotypic profile and colony formation during recovery from cytotoxic therapy-induced marrow aplasia.
    Ashkenazi YJ, Barth KC, Elfenbein GJ.
    Cancer Res; 1985 Dec 12; 45(12 Pt 1):6513-8. PubMed ID: 3933827
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status.
    Madec AM, Allannic H, Genetet N, Gueguen M, Genetet G, Fauchet R, Stefanutti A, Orgiazzi J.
    J Clin Endocrinol Metab; 1986 Jan 12; 62(1):117-21. PubMed ID: 3484386
    [Abstract] [Full Text] [Related]

  • 16. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
    Mascart-Lemone F, Delespesse G, Servais G, Kunstler M.
    Clin Exp Immunol; 1982 Apr 12; 48(1):148-54. PubMed ID: 6211314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of T lymphocytes after bone marrow transplantation using monoclonal antibodies.
    Fox R, McMillan R, Spruce W, Tani P, Mason D.
    Blood; 1982 Sep 12; 60(3):578-82. PubMed ID: 6286011
    [Abstract] [Full Text] [Related]

  • 19. Interest in and limitations of monoclonal anti-T-cell antibodies for the follow-up of renal transplant patients.
    Chatenoud L, Chkoff N, Kreis H, Bach JF.
    Transplantation; 1983 Jul 12; 36(1):45-50. PubMed ID: 6191417
    [Abstract] [Full Text] [Related]

  • 20. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S, Ueda Y, Murakawa Y, Suzuki N, Sakane T.
    J Clin Invest; 1983 Dec 12; 72(6):2060-71. PubMed ID: 6227636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.